source
- Cyclic peptide drugs gain traction as AI and hybrid synthesis aim to overcome manufacturing hurdlesOral cyclic peptides are attracting attention because they promise the convenience of small‑molecule drugs while delivering antibody‑like selectivity, a combination that is fueling interest after t…
- Webinar explores how GLP-1 obesity drugs are reshaping US healthcare and market dynamicsThe upcoming webinar titled "The Massive Scale of GLP-1s: Evolving Health, Healthcare and Markets" will examine how GLP-1 receptor agonists used for obesity are altering the U.S. health-care landsc…